Sunday, 25 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Medical Device
Peijia Medical Completes First Two Implants of Trilogy THV System in Taiwan
March 6, 2025
Company
Medical Device
Huadong Medicine’s V30 Optical Radiofrequency Device Receives NMPA Review Approval
March 6, 2025
Company
Deals
Jiangsu Nhwa Pharmaceutical Invests in NeuroThree to Develop CNS Therapies
March 6, 2025
Company
Bayer Posts Steady Q4 Growth, Pharmaceutical Sales Lead the Way
March 6, 2025
Company
NovoCare Pharmacy Offers Reduced-Cost Wegovy for Cash-Paying Patients
March 6, 2025
Company
Drug
Antengene’s Xpovio Receives Marketing Approval in Indonesia
March 6, 2025
Company
Medical Device
Sino Medical Sciences’ HT Supreme Stent System Gains Vietnamese Marketing Approval
March 6, 2025
Company
Deals
Yifan Pharma Secures Rights to Bayer’s Stivarga and Nexavar in China
March 6, 2025
Policy / Regulatory
Major Policy Directions in China’s Healthcare Arena: A Comprehensive Breakdown
March 7, 2025
Company
Drug
RongCan Biotech’s mRNA HPV Vaccine Receives FDA Clinical Approval
March 6, 2025
Company
Deals
Insilico Medicine and Tenacia Partner on AI-Driven CNS Therapies
March 6, 2025
Company
Deals
Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs
March 6, 2025
1
2
…
25
26
27
28
29
…
31
32
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?